Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. People with diabetes are at risk for diabetic retinopathy, cataract, and glaucoma.
Diabetic retinopathy is the most common diabetic eye disease in America. It is caused by changes in the blood vessels of the retina. Read more →
Ground-breaking research by Monash University scientists has demonstrated the previously unknown existence of a disease-fighting immune cell in the eye and points to potential novel ways of treating eye disorders in premature babies and diabetic adults.
The scientists, led by Professor Jennifer Wilkinson-Berka in the Central Clinical School’s new Department of Diabetes, were investigating improved ways of treating retinopathy of prematurity (ROP), which occurs in very small, prematurely born babies. Read more →
When it comes to our health, we often visit our doctor or nurse regularly to make sure our bodies are healthy. But what about our eyes? They’re not always top of mind, but they’re just as important.
During Healthy Vision Month, held each May, the National Eye Institute (NEI) reminds you to make your eye health a priority and encourages you to take important steps to protect your sight. Read more →
Retinopathy of Prematurity (ROP) causes babies to needlessly lose their vision. It is one of the leading causes of blindness in premature infants in India.
INDIA, (IAPB), April 27, 2017 — The Queen Elizabeth Diamond Jubilee Trust and the Public Health Foundation of India are launching a Retinopathy of Prematurity Initiative in the western state of Maharashtra. The project will train staff to screen for ROP, provide support services, and conduct research to tackle the disease.
India has the largest number of preterm births in the world. “Our goal is to help support sustainable and scalable services for the detection and prevention of severe retinopathy of prematurity which are integrated into the Government of India’s health care system”, explained Dr. Astrid Bonfield, Chief Executive at the Trust. Read more →
In a recently conducted Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study, researchers discovered that intensive blood sugar control appears to reduce the risk of eye disease progression in people with type 2 diabetes, and who are likewise at risk of diabetic retinopathy.
In the new study, participants on intensive therapy had average hemoglobin A1C levels and the researchers found that the therapy had cut retinopathy progression by about one-third and posed a possible treatment with continuous use of fenofibrate.
Previous studies have reported similar findings, the researchers said.
The study was scheduled to be presented in New Orleans. Findings presented at meetings are generally viewed as preliminary until published in a peer-reviewed journal.